SIC 3841 – Surgical and Medical Instruments and Apparatus
| Valuation | |
|---|---|
| Market Cap ($M) | 41.39 |
| Enterprise Value ($M) | 39.66 |
| Book Value ($M) | 2.05 |
| Book Value / Share | 0.13 |
| Price / Book | 20.21 |
| NCAV ($M) | 0.94 |
| NCAV / Share | 0.06 |
| Price / NCAV | 44.27 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -3.17 |
| Return on Assets (ROA) | -3.05 |
| Return on Equity (ROE) | -42.06 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.89 |
| Current Ratio | 1.93 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 2.30 |
| Assets | 3.42 |
| Liabilities | 1.37 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.43 |
| Operating Income | -7.23 |
| Net Income | -7.73 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -4.85 |
| Cash from Investing | 0.00 |
| Cash from Financing | 6.91 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D | STELLARS CAPITAL PRIVATE I Ltd | 13.30 | ||
| 13D/A | DST Capital LLC | 25.90 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| GTHP – Guided Therapeutics, Inc. | HDII – Hypertension Diagnostics, Inc. |
| HLTT – Healthtech Solutions Inc. | IDXG – Interpace Biosciences, Inc. |
| INLB – Item 9 Labs Corp. |
Financial data and stock pages provided by
Fintel.io